Results 41 to 50 of about 701,982 (381)
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Pathogens, 2020 Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus,
Artur Słomka +2 more
doaj +1 more source
A brief overview of current drug repurposing approaches for COVID-19 management [PDF]
, 2020 This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares +1 more
core +2 more sources
Military Medical Research, 2020 An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention.
Yanrong Guo +8 more
semanticscholar +1 more source
Exploration, 2022 Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic.
Ziqi Wang +3 more
doaj +1 more source
Medicine Science, 2020 COVID-19 (coronavirus disease 2019) is a viral infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a World Health Organization (WHO) declared pandemic.
Monira Taha Ismail +1 more
doaj +1 more source
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
JAMA cardiology, 2020 This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
T. Guo +9 more
semanticscholar +1 more source
A role for quercetin in coronavirus disease 2019 (COVID‐19) [PDF]
Phytotherapy Research, 2020 Several months ago, an outbreak of pneumonia of unknown aetiology was detected in Wuhan City (China) and the aetiological agent of the atypical pneumonia was isolated by the Chinese authorities as novel coronavirus (2019‐nCoV or SARS‐CoV‐2). The WHO announced this new disease was to be known as “COVID‐19.” When looking for new antiviral compounds ...
Derosa, Giuseppe +3 more
openaire +4 more sources
Pharmaceutical Sciences and Research, 2020 Coronavirus disease 2019 (COVID-19) is the disease caused by the highly transmittable novel coronavirus (SARS-CoV-2) infections. The disease was found at the end of December 2019, in Wuhan, China, and quickly spread worldwide with a higher mortality rate
Nuriza Ulul Azmi +2 more
doaj +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
, 2020 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source
Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in Turkey
The Annals of Clinical and Analytical Medicine, 2021 Aim: Chest CT plays an important role in the treatment and diagnosis of COVID-19. It is important to remember that patients with RT-PCR test positive for COVID-19 infection may have normal chest CT.
Ş. Arslan +4 more
semanticscholar +1 more source